Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

NAPLEX > Cardiovascular Conditions > Flashcards

Cardiovascular Conditions Flashcards

1
Q

Classifications of cholesterol types, and levels with TG

A

417

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of dyslipidemia

A

418

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Calculating ASCVD risk

A

418

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Select drugs and conditions that raise LDL or TG levels

A

418

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Non-drug treatment of dyslipidemia

A

419

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Natural products to treat dyslipidemia

A

419

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Statin treatment intensity definitions and selection options

A

419/420

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Equivalent doses of statins

A

420

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Managing myalgias from statins

A

420

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Statin drug names and doses

A

421

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Statin safety, side effects, and monitoring

A

421

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Statin drug interactions

A

421

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Determining need for add-on treatments

A

422

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ezetimibe (Zetia)

A

422

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9)

A

423

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bile acid sequestrants or binding resins

A

423

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Fibrates

A

424

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Niacin

A

425

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Fish oils

A

426

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Other dyslipidemia drug treatments

A

426

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Key counseling points for dyslipidemia

A

427

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pathophysiology of hypertension

A

428/429

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Screening and diagnosis of hypertension

A

430

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Key drugs that increase blood pressure

A

430

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Lifestyle management in hypertension

A

430

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Natural products for hypertension

A

431

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Guideline recommendations on treatment

A

431

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Hypertension in pregnancy

A

431

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Combination drug names

A

432

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Thiazide-type diuretics

A

432/433

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Calcium channel blockers: dihydropyridine

A

434

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Calcium channel blockers: non dihydropyridine

A

435

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Angiotensin-converting enzyme inhibitors (ACE)

A

436

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Angiotensin receptor blockers (ARB)

A

437

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Direct renin inhibitor

A

437

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Potassium-sparing diuretics

A

438

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Beta-blockers: B-1 selective

A

439

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Beta-blockers: B-1 selective with nitric oxide-dep vasodilation

A

439

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Beta-blockers: Beta nonselective

A

440

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Beta-blockers: Beta and alpha-1 nonselective

A

440

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Centrally acting alpha-2 adrenergic agonists

A

441

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Direct vasodilators

A

441

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Hypertensive urgency and emergency

A

442

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Key counseling points for hypertension

A

442

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Evaluation of stable ischemic HD

A

444

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Non-drug treatment for SIHD

A

444

47
Q

Treatment approach for SIHD

A

444

48
Q

Antiplatelet drugs: aspirin

A

445

49
Q

Antiplatelet drugs: clopidogrel (Plavix)

A

445

50
Q

Dual antiplatelet therapy (DAPT)

A

445

51
Q

Antianginal treatments

A

446

52
Q

Nitroglycerin in SIHD

A

447

53
Q

Key counseling points in SIHD

A

448

54
Q

Risk factors in acute coronary syndrome

A

449

55
Q

Diagnosis, signs, and symptoms of ACS

A

449/450

56
Q

Comparing UA, NSTEMI, and STEMI

A

450

57
Q

PCI or medical management

A

450

58
Q

Drug treatment options for ACS

A

450

59
Q

Order of operations for drugs in ACS

A

451

60
Q

Medications to avoid in the acute setting of ACS

A

451

61
Q

Antiplatelet drugs used in ACS

A

452/453

62
Q

Glycoprotein IIb/IIIa receptor antagonists

A

454

63
Q

Protease-activated receptor-1 antagonists

A

454

64
Q

Fibrinolytic

A

455

65
Q

Secondary prevention of ACS

A

456

66
Q

Diagnosis of HF through ejection fraction

A

458

67
Q

Classification of HF

A

458

68
Q

Signs and symptoms of HF

A

458

69
Q

Pathophysiology of HF

A

459

70
Q

Lifestyle management of HF

A

459

71
Q

Key drugs that cause or worsen HF

A

459

72
Q

Types of HF

A

461

73
Q

Initial treatment of HFrEF

A

460

74
Q

Neprilysin inhibitor

A

461

75
Q

Guideline-directed ACEI/ARBs

A

462

76
Q

Guideline-directed beta-blockers

A

463

77
Q

Aldosteron receptor antagonists

A

464

78
Q

Sodium-glucose cotransporter 2 inhibitors (SGLT2I)

A

Diabetes chapter

79
Q

Loop diuretics

A

465

80
Q

Hydralazine with nitrate

A

466

81
Q

Ivabradine

A

467

82
Q

Digoxin

A

467/468

83
Q

Vericiguat

A

468

84
Q

Potassium pills

A

469

85
Q

Action plan for HF

A

470

86
Q

Key counseling points for HF

A

471

87
Q

Normal cardiac conduction pathway

A

473

88
Q

Normal cardiac action potential

A

474

89
Q

Types of arrhythmias

A

474/475

90
Q

Key drugs that prolong the QT interval

A

475

91
Q

Classification of antiarrhythmic drugs

A

476

92
Q

Types of AF

A

476

93
Q

Rate control of AF

A

477

94
Q

Rhythm control of AF

A

477

95
Q

Stroke prophylaxis in AF

A

477

96
Q

Amiodarone

A

478

97
Q

Digoxin

A

479

98
Q

Non-DHP CCB in AF

A

479

99
Q

Class Ia antiarrhythmics

A

480/481

100
Q

Class Ib antiarrhythmics

A

481

101
Q

Class Ic antiarrhythmics

A

481

102
Q

Class III antiarrhythmics

A

482

103
Q

Adenosine

A

483

104
Q

Key counseling points for arrhythmias

A

483

105
Q

Types of strokes

A

484

106
Q

Risk factors for stroke

A

485

107
Q

Signs and symptoms of stroke

A

485

108
Q

Alteplase

A

486

109
Q

Bleeding risk with alteplase

A

485

110
Q

Treatment of stroke

A

486

111
Q

Secondary prevention of stroke

A

487/488

112
Q

Types of hemorrhagic stroke

A

489

113
Q

Treatment of ICH

A

489

114
Q

Treatment of SAH

A

490

NAPLEX (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions